CAT
47
3
KHC
11
2
DIS
70
2
CLX
65
2
EBAY
42
2
GRMN
53
3
ROST
60
3
PH
60
5
AN
49
2
XYL
29
4
IBM
53
2
CF
47
5
EFX
43
3
FIS
43
5
HSIC
42
2
STT
48
4
EW
55
5
XEL
48
11
MSI
52
3
CSCO
63
5
CAT
47
3
KHC
11
2
DIS
70
2
CLX
65
2
EBAY
42
2
GRMN
53
3
ROST
60
3
PH
60
5
AN
49
2
XYL
29
4
IBM
53
2
CF
47
5
EFX
43
3
FIS
43
5
HSIC
42
2
STT
48
4
EW
55
5
XEL
48
11
MSI
52
3
CSCO
63
5
Financhill
Back

Expedia Group Vs. Novo Nordisk AS Industry Stock Comparison

Buy
83

EXPE
Expedia Group

Last Price:
$184.73
Seasonality Move:
-0.48%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
83
Expedia Group (EXPE) is a Buy

Is Expedia Group a Buy, Sell or Hold?

  • The current Expedia Group [EXPE] share price is $184.71. The Score for EXPE is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • EXPE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EXPE Stock Price Chart

What is Expedia Group's stock price today?

  • The Expedia Group share price today is $184.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

EXPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.82 Buy
Relative Strength Index (14 RSI): 55.58 Buy
Chaikin Money Flow: 3285448 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (180.17 - 188.17) Buy
Bollinger Bands (100): (132.82 - 177.24) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

EXPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 182.68 Buy
20-day SMA: 185.14 Sell
50-day SMA: 173.89 Buy
200-day SMA: 140.84 Buy
8-day EMA: 182.57 Buy
20-day EMA: 182.63 Buy
50-day EMA: 173.97 Buy
200-day EMA: 148.22 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Expedia Group Earnings Growth & EXPE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.17 per share, and an increase next year of $2.33 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Expedia Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):